Antiepileptics

Hwang, 2016, The efficacy of gabapentin/pregabalin in improving pain after tonsillectomy: a meta-analysis, Laryngoscope, 126, 357, 10.1002/lary.25636 Edwards, 2016, Gabapentin use in the neonatal intensive care unit, J Pediatr, 169, 310, 10.1016/j.jpeds.2015.10.013 Mimenza, 2016, Clinical trial assessing the efficacy of gabapentin plus B complex (B1/B12) versus pregabalin for treating painful diabetic neuropathy, J Diabetes Res, 2016, 4078695 Fallon, 2016, Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain, J Clin Oncol, 34, 550, 10.1200/JCO.2015.63.8221 Dong, 2016, The effect of pregabalin on acute postoperative pain in patients undergoing total knee arthroplasty: a meta-analysis, Int J Surg, 34, 148, 10.1016/j.ijsu.2016.08.521 Gurunathan, 2016, The effect of pregabalin and celecoxib on the analgesic requirements after laparoscopic cholecystectomy: a randomized controlled trial, J Anesth, 30, 64, 10.1007/s00540-015-2078-9 Raskin, 2016, Pregabalin in patients with painful diabetic peripheral neuropathy using an NSAID for other pain conditions: a double-blind crossover study, Clin J Pain, 32, 203, 10.1097/AJP.0000000000000254 Deshmukh, 2016, Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine, Neurotoxicol Teratol, 54, 5, 10.1016/j.ntt.2016.01.001 Shah, 2016, Safety and effectiveness of divalproex sodium extended release containing regimen in Indian patients with bipolar I disorder in continuation phase: results of EASED registry, Asian J Psychiatr, 20, 32, 10.1016/j.ajp.2015.11.009 Knights, 2016, Sodium valproate-induced Fanconi type proximal renal tubular acidosis, BMJ Case Rep, 10.1136/bcr-2015-213418 Cook, 2016, Pharmacokinetics and clinical utility of valproic acid administered via continuous infusion, CNS Drugs, 30, 71, 10.1007/s40263-015-0304-5 Stevens, 2016, Hepatic dysfunction as a complication of combined valproate and ketogenic diet, Pediatr Neurol, 54, 82, 10.1016/j.pediatrneurol.2015.10.006 Spilioti, 2016, Valproate effect on ketosis in children under ketogenic diet, Eur J Paediatr Neurol, 20, 555, 10.1016/j.ejpn.2016.04.003 Brigo, 2016, Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: results of an indirect comparison meta-analysis of RCTs, Seizure, 42, 29, 10.1016/j.seizure.2016.08.007 Stockis, 2016, Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration, Epilepsy Res, 128, 163, 10.1016/j.eplepsyres.2016.11.001 Gironell, 2016, Ethosuximide for essential tremor: an open-label trial, Tremor Other Hyperkinet Mov (N Y), 6, 378, 10.5334/tohm.306 IJff, 2016, The cognitive profile of ethosuximide in children, Paediatr Drugs, 18, 379, 10.1007/s40272-016-0187-z Arzimanoglou, 2016, Safety of levetiracetam among infants younger than 12 months—results from a European multicenter observational study, Eur J Paediatr Neurol, 20, 368, 10.1016/j.ejpn.2016.01.006 Artemiadis, 2016, Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy, Epilepsy Behav, 55, 84, 10.1016/j.yebeh.2015.12.025 Hakami, 2016, Monotherapy with levetiracetam versus older AEDs: a randomized comparative trial of effects on bone health, Calcif Tissue Int, 98, 556, 10.1007/s00223-016-0109-7 Chowdhury, 2016, Pharmacological outcomes in juvenile myoclonic epilepsy: support for sodium valproate, Epilepsy Res, 119, 62, 10.1016/j.eplepsyres.2015.11.012 Kowski, 2016, Specific adverse effects of antiepileptic drugs—a true-to-life monotherapy study, Epilepsy Behav, 54, 150, 10.1016/j.yebeh.2015.11.009 Ju, 2016, Levetiracetam: probably associated diurnal frequent urination, Am J Ther, 23, e624, 10.1097/MJT.0000000000000201 Chung, 2016, Levetiracetam extended release for the treatment of patients with partial-onset seizures: a long-term, open-label follow-up study, Epilepsy Res, 120, 7, 10.1016/j.eplepsyres.2015.11.017 Bayram, 2016, Drug reaction with eosinophilia and systemic symptoms syndrome induced by levetiracetam in a pediatric patient, J Emerg Med, 50, e61, 10.1016/j.jemermed.2015.10.004 Page, 2016, Cardiovascular toxicity with levetiracetam overdose, Clin Toxicol (Phila), 54, 152, 10.3109/15563650.2015.1115054 Xu, 2016, The efficacy and safety of rufinamide in drug-resistant epilepsy: a meta-analysis of double-blind, randomized, placebo controlled trials, Epilepsy Res, 120, 104, 10.1016/j.eplepsyres.2016.01.001 Arzimanoglou, 2016, Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox–Gastaut syndrome: an interim analysis from a multicenter, randomized, active-controlled, open-label study, Eur J Paediatr Neurol, 20, 393, 10.1016/j.ejpn.2015.12.015 Jaraba, 2017, Rufinamide in children and adults in routine clinical practice, Acta Neurol Scand, 135, 122, 10.1111/ane.12572 Bektaş, 2016, Aggravation of atonic seizures by rufinamide: a case report, Brain Dev, 38, 654, 10.1016/j.braindev.2016.02.005 Yi, 2016, Efficacy and acceptability of oxcarbazepine vs carbamazepine with betahistine mesilate tablets in treating vestibular paroxysmia: a retrospective review, Postgrad Med, 128, 492, 10.1080/00325481.2016.1173515 Hase, 2016, Bronchoscopic investigation of atypical drug-induced hypersensitivity syndrome showing viral lung involvement, Intern Med, 55, 2691, 10.2169/internalmedicine.55.6347 Can, 2016, Carbamazepine-induced atrioventricular block in an elderly woman, Turk Kardiyol Dern Ars, 44, 68 Holtkamp, 2016, Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy, Acta Neurol Scand, 134, 76, 10.1111/ane.12574 Steinhoff, 2016, A long-term noninterventional safety safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures, Epilepsy Behav, 58, 35, 10.1016/j.yebeh.2016.02.041 Hong, 2016, Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: a randomized, double-blind, placebo-controlled study, Epilepsy Res, 127, 267, 10.1016/j.eplepsyres.2016.08.032 Vossler, 2016, Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: results from a multicenter, openlabel trial, Epilepsia, 57, 1625, 10.1111/epi.13502 Foldvary-Schaefer, 2016, Lacosamide tolerability in adult patients with partial-onset seizures: impact of planned reduction and mechanism of action of concomitant antiepileptic drugs, Epilepsy Behav, 57, 155, 10.1016/j.yebeh.2016.02.007 Villanueva, 2016, NEOPLASM study: real-life use of lacosamide in patients with brain tumor-related epilepsy, Epilepsy Behav, 65, 25, 10.1016/j.yebeh.2016.09.033 Borzi, 2016, Lacosamide with temporal lobe epilepsy: an observational muticentric open-label study, Epilepsy Behav, 58, 111, 10.1016/j.yebeh.2016.03.011 Arkilo, 2016, Clinical experience of intravenous lacosamide in infants and young children, Eur J Paediatr Neurol, 20, 212, 10.1016/j.ejpn.2015.12.013 d’Orsi, 2016, Intravenous lacosamide in seizure emergencies: observations from a hospitalized in-patient adult population, Seizure, 42, 20, 10.1016/j.seizure.2016.09.004 Lancman, 2016, The effects of lacosamide of cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy, Epilepsy Behav, 61, 27, 10.1016/j.yebeh.2016.04.049 Elger, 2016, Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: a small phase IIIb, prospective, multicenter, open-label trial, Epilepsy Behav, 62, 1, 10.1016/j.yebeh.2016.05.023 Poddar, 2016, Intravenous lacosamide in pediatric status epilepticus: an open-label efficacy and safety study, Pediatr Neurol, 61, 83, 10.1016/j.pediatrneurol.2016.03.021 Meador, 2016, Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine, Epilepsy Behav, 62, 267, 10.1016/j.yebeh.2016.07.007 Ghandourah, 2016, Bronchiolitis obliterans organising pneumonia associated with anticonvulsant hypersensitivity syndrome induced by lamotrigine, BMJ Case Rep, 10.1136/bcr-2014-207182 Parker, 2016, Development of an incipient Stevens–Johnson reaction while on a stable dose of lamotrigine, Australas Psychiatry, 24, 193, 10.1177/1039856215612993 Matarazzo, 2016, Drug-related eyelid nystagmus: two cases of a rare clinical phenomenon related to carbamazepine and derivatives, Clin Neuropharmacol, 39, 49, 10.1097/WNF.0000000000000125 Garoufi, 2016, Weight gain in children on oxcarbazepine monotherapy, Epilepsy Res, 122, 110, 10.1016/j.eplepsyres.2016.03.004 Tassaneeyakul, 2016, Associations between HLA class I and cytochrome P450 2CP genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population, Pharmacogenet Genomics, 26, 225, 10.1097/FPC.0000000000000211 Guacci, 2016, Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations, Seizure, 34, 26, 10.1016/j.seizure.2015.11.004 Veeravigrom, 2016, Phenytoin toxicity in two-month-old Thai infant with CYP2C9 gene polymorphism—a case report, Brain Dev, 38, 136, 10.1016/j.braindev.2015.05.001 Kheir, 2016, Phenytoin-associated granulomatous pulmonary vasculitis, Am J Ther, 23, e311, 10.1097/MJT.0000000000000006 Dash, 2016, Evaluation of safety and efficacy of zonisamide in adult patients with partial, generalized, and combined seizures: an open labeled, noncomparative, observational Indian study, Ther Clin Risk Manag, 12, 327, 10.2147/TCRM.S91085 Shah, 2016, Evaluating the safety and efficacy of felbamate in the context of a black box warning: a single center experience, Epilepsy Behav, 56, 50, 10.1016/j.yebeh.2016.01.006 Glauser, 2016, Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: a phase III post-hoc analysis, Epilepsy Res, 119, 34, 10.1016/j.eplepsyres.2015.11.014 Majid, 2016, Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials, Br J Clin Pharmacol, 82, 422, 10.1111/bcp.12951 Juhl, 2016, Perampanel as add-on treatment in refractory focal epilepsy. The Dianalund experience, Acta Neurol Scand, 134, 374, 10.1111/ane.12558 Brodie, 2016, Prospective audit with adjunctive perampanel: preliminary observations in focal epilepsy, Epilepsy Behav, 54, 100, 10.1016/j.yebeh.2015.11.002 Jhagroo, 2015, Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia, Br J Clin Pharmacol, 81, 131, 10.1111/bcp.12751 Feinn, 2016, Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care, J Clin Psychiatry, 77, e278, 10.4088/JCP.15m10053 Wang, 2016, Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital, Eur Rev Med Pharmacol Sci, 20, 993 Wu, 2016, Spermatorrhea and loss of libido induced by topiramate: first case report and review of literature, Clin Neuropharmacol, 39, 1, 10.1097/WNF.0000000000000187 Karalezli, 2016, Topiramate-induced changes in anterior chamber angle and choroidal thickness, Eye Contact Lens, 42, 120, 10.1097/ICL.0000000000000157 Sedighi, 2016, Topiramate-induced paresthesia is more frequently reported by migraine than epileptic patients, Neurol Sci, 37, 585, 10.1007/s10072-015-2458-9 Canel, 2016, Topiramate-induced severe heatstroke in an adult patient: a case report, J Med Case Reports, 10, 95, 10.1186/s13256-016-0835-5 Powers, 2017, Trial of amitriptyline, topiramate, and placebo for pediatric migraine, N Engl J Med, 376, 115, 10.1056/NEJMoa1610384 Gidal, 2016, Deconstructing tolerance with clobazam: post hoc analyses from an open-label extension study, Neurology, 87, 1806, 10.1212/WNL.0000000000003253 Wang, 2016, Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital, Eur Rev Med Pharmacol Sci, 20, 993 Si, 2016, A preliminary observation of the adverse effects of phenobarbital among patients with convulsive epilepsy in rural West China, Epilepsy Behav, 54, 65, 10.1016/j.yebeh.2015.11.007 Okumura, 2016, Efficacy and tolerability of high-dose phenobarbital in children with focal seizures, Brain Dev, 38, 414, 10.1016/j.braindev.2015.10.011 Spiller, 2016, Review of toxicity and trends in the use of tiagabine as reported to US poison centers from 2000 to 2012, Hum Exp Toxicol, 35, 109, 10.1177/0960327115579206 Krauss, 2016, Sabril® registry 5-year results: characteristics of adult patients treated with vigabatrin, Epilepsy Behav, 56, 15, 10.1016/j.yebeh.2015.12.004 Nass, 2016, Adjunctive retigabine in refractory focal epilepsy: postmarketing experience at four tertiary epilepsy care centers in Germany, Epilepsy Behav, 56, 54, 10.1016/j.yebeh.2015.12.034